United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17856-0691_3633ef65-d53d-4728-e063-6394a90a6205
- Product NDC
- 17856-0691
- Form
- SOLUTION
- Composition / generic term
- Ondansetron
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101217
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1.5 mL in 1 SYRINGE (17856-0691-1) · 17856-0691-1
- 2.5 mL in 1 SYRINGE, PLASTIC (17856-0691-2) · 17856-0691-2
- 2.5 mL in 1 SYRINGE, PLASTIC (17856-0691-4) · 17856-0691-4
- 5 mL in 1 CUP (17856-0691-5) · 17856-0691-5
- 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-6) / 1.25 mL in 1 SYRINGE · 17856-0691-6
- 48 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-7) / 1.9 mL in 1 SYRINGE · 17856-0691-7
- 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-8) / 2.5 mL in 1 SYRINGE · 17856-0691-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →